David H Abramson

21PUBLICATIONS
59CO-AUTHORS
Molecular targetsAutoimmunityOptical technologyVenereologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|May 15, 2026
How We Approach Intraocular Retinoblastoma in 2026: Agreement and Disagreement in Four Referral Centers in the USA and Europe.

|May 13, 2026
Dulaglutide-Associated Choroidal Lymphoid Hyperplasia.

|Jan 21, 2025
Machine learning demonstrates clinical utility in distinguishing retinoblastoma from pseudo retinoblastoma with RetCam images.

Owen Cruz-Abrams, Ricardo Dodds Rojas, David H Abramson

|Oct 08, 2024
Vitreoretinal lymphoma: the importance of cerebral spinal fluid evaluation at initial diagnosis.

Rebecca F Silverman, David H Abramson, Julia Canestraro

|Sep 04, 2024
What have we learned about intraarterial chemotherapy (Ophthalmic Artery Chemosurgery) for retinoblastoma in the past 18 years? The third A. Linn Murphree Lecture.

David H Abramson

|Aug 16, 2024
The Impact of Li-Fraumeni and Germline Retinoblastoma Mutations on Leiomyosarcoma Initiation, Outcomes, and Genetic Testing Recommendations.

Josephine K Dermawan, David H Abramson, Sarah Chiang

Pageof 4

Frequent Collaborators

6 joint publications

Jasmine H Francis

4 joint publications

Ira J Dunkel

3 joint publications

Guillermo L Chantada

2 joint publications

Rosario Aschero